Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by GROGAN DONNA ROY. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 11 disclosures have been logged. Activity tracked since 3 October 2022. The latest transaction was filed on 1 April 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations11 total
9,581 shares@ US$1.4359.6% of flowCommon StockSEC:0001662579-25-000025:0
3,757 shares@ US$3.6610.0% of flowCommon StockSEC:0001662579-25-000004:0
2,474 shares@ US$5.569.4% of flowCommon StockSEC:0001662579-24-000090:0
2,836 shares@ US$4.859.7% of flowCommon StockSEC:0001662579-24-000064:0
1,697 shares@ US$8.109.7% of flowCommon StockSEC:0001662579-24-000036:0
2,108 shares@ US$6.529.4% of flowCommon StockSEC:0001662579-24-000004:0
8,089 shares@ US$1.709.9% of flowCommon StockSEC:0001662579-23-000107:0
4,858 shares@ US$2.839.5% of flowCommon StockSEC:0001662579-23-000066:0
4,298 shares@ US$3.209.5% of flowCommon StockSEC:0001662579-23-000044:0
1,763 shares@ US$6.387.9% of flowCommon StockSEC:0001662579-23-000005:0
819 shares@ US$8.695.5% of flowCommon StockSEC:0001662579-22-000006:0